FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 80 filers reported holding FORTRESS BIOTECH INC in Q3 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,000 | 0.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000 | -37.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $27,000 | -46.0% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $50,000 | -21.9% | 20,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $64,000 | -9.9% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $71,000 | 0.0% | 20,000 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $71,000 | +12.7% | 20,000 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $63,000 | -22.2% | 20,000 | 0.0% | 0.00% | -42.9% |
| Q3 2020 | $81,000 | +50.0% | 20,000 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $54,000 | +42.1% | 20,000 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $38,000 | -25.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $51,000 | +82.1% | 20,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $28,000 | -6.7% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $30,000 | -16.7% | 20,000 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $36,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,247,180 | $2,727,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 760,992 | $639,000 | 0.66% |
| TANG CAPITAL MANAGEMENT LLC | 3,342,801 | $2,808,000 | 0.43% |
| Nantahala Capital Management | 8,758,648 | $7,356,000 | 0.37% |
| SHIKIAR ASSET MANAGEMENT INC | 800,000 | $672,000 | 0.26% |
| Oasis Management Co Ltd. | 985,222 | $827,000 | 0.15% |
| CPWM, LLC | 781,767 | $657,000 | 0.06% |
| Urban Wealth Management, LLC | 7,635 | $6,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 12,996 | $11,000 | 0.02% |
| Ergoteles LLC | 344,300 | $289,000 | 0.01% |